Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Derived from transgenic multicellular eukaryote
Patent
1982-06-07
1985-04-23
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Derived from transgenic multicellular eukaryote
424162, A61K 3304, A61K 3338
Patent
active
045129770
ABSTRACT:
There are provided therapeutic compositions comprising certain selenium-containing compounds which exhibit therapeutic benefits in mammal hosts including humans. The selenium compounds in accordance with this invention are preferably water soluble organic or inorganic compounds containing selenium such as alkali metal selenites and selenates. Among the therapeutic benefits exhibited by these compositions are the reduction in severity from and improvements in recovery from physically induced damage to body tissue which includes damage caused by surgical incisions, lacerations and burns.
REFERENCES:
patent: 3928578 (1975-12-01), Burns et al.
Chemical Abstracts, vol. 85:8817a, (1976).
Roberts, Toxicology and Applied Pharmacology, 5, pp. 500-506, (1963).
Rogers' Inorganic Pharmaceutical Chemistry, by Soine et al., published by Henry Kimpton, London, 1957, pp. 587-588.
Cohen, L. B., Amer. J. Ophth. 38, 560-562, (1954).
Slinger et al., Arch. Dermat. and Syph. 64, pp. 41-48, (1951).
Friedman Stanley J.
Lundy Research Laboratories, Inc.
LandOfFree
Therapeutic selenium compositions and the use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic selenium compositions and the use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic selenium compositions and the use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-36658